KPV Tripeptide

KPV is a three-part fragment of alpha-MSH, a hormone best known for skin pigment. This fragment carries the inflammation-calming signal instead.

It's studied in skin and gut-barrier research — how inflammation is turned down and how protective barriers respond.

Cell studies showed reduced inflammation signals without triggering pigment. Human benefit is not established.

Distinguishes established clinical findings from early human trials, animal experiments, or laboratory cell culture findings. No human dosing, injection instructions, or treatment recommendations are provided.

KPV is an investigational research chemical. It is not approved by the FDA for medical or consumer use.

BBOHC LABS research reagents are non-clinical materials. An FDA approval for a finished medicine containing the same active ingredient does not imply that BBOHC's investigational research vial is FDA-approved.

Low toxicity in cellular assays.

• Kannengiesser K et al. Melanocortin peptide KPV in epithelial cells. Inflamm Bowel Dis. 2008.

Specific citations are provided for literature context. Product purity & lot verification documentation available on request.